Mirati Therapeutics Inc

Mirati Therapeutics Inc is a commercial-stage biotechnology company dedicated to developing innovative therapeutics for cancer. The US-based company aims to improve the lives of patients worldwide by addressing unmet medical needs in oncology. The company operates globally, conducting research and clinical trials across various regions. Operating within the biopharmaceutical sector, Mirati Therapeutics Inc focuses on creating precision medicines. It targets specific genetic drivers of cancer to provide more effective treatments for patients. The company's work aims to transform the standard of care for challenging cancers. Monitor the MRTX share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.